You are here

Sanofi to pay US$11.9m to resolve US drug kickback probe

nz_Sanofi _290242.jpg
Sanofi SA has agreed to pay nearly US$11.9 million to resolve allegations that it used a charity that helps Medicare patients cover out-of-pocket drug costs as a way to pay kickbacks aimed at encouraging the use of a high-priced multiple sclerosis drug.

[BOSTON] Sanofi SA has agreed to pay nearly US$11.9 million to resolve allegations that it used a charity that helps Medicare patients cover out-of-pocket drug costs as a way to pay kickbacks aimed at encouraging the use of a high-priced multiple sclerosis drug.

The US Justice Department on Friday said Sanofi was the latest company to settle claims stemming from an industry-wide probe of drugmakers' financial support of patient assistance charities.

Sanofi did not admit wrongdoing as part of the settlement.

REUTERS

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes